New Ray Medicine International Holding Limited

New Ray Medicine International Holding Limited is an investment holding company that distributes and trades pharmaceutical and related products in the People's Republic of China. Its products include levocarnitine injection for muscular dystrophy, cardiomyopathy, myocardial infarction, angina, and parenteral nutrition; thymosin a1 for hepatitis and impaired immunity; and antibiotics such as cefamandole nafate, ceftizoxime sodium, and isepamicin sulfate for various infections. It also offers alanyl glutamine, cefixime dispersible tablets, and clostridium butyricum capsules, and provides marketing and promotion services. Founded in 2001, it is headquartered in Hangzhou, China.